Assessment of complications and surgical timing in post-COVID-19 thoracotomy patients: A single-center experience.

Background: This study aims to assess the complications in post-novel coronavirus disease 2019 (COVID-19) thoracotomy patients and to evaluate the time interval between infection and surgery and the effect of vaccine timing and vaccine type in these patients. Methods: Between May 2020 and January 2022, a total of 74 patients (34 males, 40 females; mean age: 54.5±13.7 years; range, 22 to 27 years) who had COVID-19 infection and underwent thoracic surgery were retrospectively analyzed. Data including demographic and clinical characteristics, the surgery type, length of intensive care unit and hospital stay, and postoperative complications were recorded. Complications were defined as respiratory, cardiac, thrombotic, and other complications. The time period between COVID-19 infection and surgery was noted. All patients were questioned regarding their vaccination status. Results: Having a symptomatic COVID-19 infection did not significantly affect the development of postoperative complications and length of intensive care unit or hospital stay. Thoracic involvement was the main factor which affected the length of intensive care unit and hospital stay during COVID-19 infection (p=0.004 and p=0.003, respectively). Conclusion: Our study results suggest that the length of hospital and intensive care unit stay is related to the time period between infection and surgery. The longer that the patient waits after COVID-19 infection, the less time that the patient stays in the hospital.